カテゴリー： 世界, 医療/バイオ, 9Dimen Research

世界のオピオイド誘発性便秘市場2023-2027

【英語タイトル】Global Opioid-Induced Constipation Market Research Report 2023-2027

9Dimen Researchが出版した調査資料（DMN23J1632）・商品コード：DMN23J1632
・発行会社（調査会社）：9Dimen Research
・発行日：2023年7月
・ページ数：142
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,200 ⇒換算￥486,400見積依頼/購入/質問フォーム
Global/Corporate User（法人閲覧用）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

米中貿易戦争、ロシア・ウクライナ戦争、世界経済の不安定性と不確実性は世界のオピオイド誘発性便秘市場に大きな影響を与えるでしょう。オピオイド誘発性便秘市場レポートは、主要地域（北アメリカ、ヨーロッパ、アジア太平洋）と主要国（アメリカ、ドイツ、英国、日本、韓国、中国）に焦点を当てた、世界の主要地域の市場状況に関する専門的かつ包括的な調査レポートです。このレポートでは、世界のオピオイド誘発性便秘市場規模は 2023年にXX百万ドルと評価され、2027年末までにXX百万ドルに達すると予測されており、2023年から2027年にかけてXX%のCAGRで成長すると予測されています。
本調査レポートに記載されている主要な企業は、AstraZeneca、Bausch Health Companies、Daiichi Sankyo、Ironwood Pharmaceuticals、Mallinckrodt Plc、Merck & Co. 、Novartis AG、Pfizer、Takeda Pharmaceuticalなどです。

本レポートは、世界のオピオイド誘発性便秘市場（2023年-2027年）について調査・分析し、オピオイド誘発性便秘の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別（一般型、……など）、用途別（医療、……など）のセグメント情報も収録しています。

・オピオイド誘発性便秘の市場概要
・オピオイド誘発性便秘の上流・下流市場分析
・オピオイド誘発性便秘のアジア市場：市場分析（製品開発、競争環境、市場動向等）
・オピオイド誘発性便秘のアジア市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘のアジア市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・オピオイド誘発性便秘のアジア市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘の北アメリカ市場：市場分析（製品開発、競争環境、市場動向等）
・オピオイド誘発性便秘の北アメリカ市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘の北アメリカ市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・オピオイド誘発性便秘の北アメリカ市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘のヨーロッパ市場：市場分析（製品開発、競争環境、市場動向等）
・オピオイド誘発性便秘のヨーロッパ市場：市場規模（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘のヨーロッパ市場：主要メーカー分析（製品、用途、生産量、価格、企業連絡先等）
・オピオイド誘発性便秘のヨーロッパ市場：市場予測（生産規模、市場シェア、需要、輸出・輸入等）
・オピオイド誘発性便秘のマーケティングチャネル分析
・マクロ経済分析（中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済）
・オピオイド誘発性便秘の投資可能性分析
・オピオイド誘発性便秘の世界市場規模（2018年-2023年推移、2023年-2027年予測）
...

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Opioid-Induced Constipation Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Opioid-Induced Constipation market is valued at USD XX million in 2023 and is projected to reach USD XX million by the end of 2027, growing at a CAGR of XX% during the period 2023 to 2027.

The report firstly introduced the Opioid-Induced Constipation basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
AstraZeneca
Bausch Health Companies
Daiichi Sankyo
Ironwood Pharmaceuticals
Mallinckrodt Plc
Merck & Co.
Novartis AG
Pfizer
Takeda Pharmaceutical
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
General Type
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Opioid-Induced Constipation for each application, including-
Medical
……

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Part I Opioid-Induced Constipation Industry Overview

Chapter One Opioid-Induced Constipation Industry Overview
1.1 Opioid-Induced Constipation Definition
1.2 Opioid-Induced Constipation Classification Analysis
1.2.1 Opioid-Induced Constipation Main Classification Analysis
1.2.2 Opioid-Induced Constipation Main Classification Share Analysis
1.3 Opioid-Induced Constipation Application Analysis
1.3.1 Opioid-Induced Constipation Main Application Analysis
1.3.2 Opioid-Induced Constipation Main Application Share Analysis
1.4 Opioid-Induced Constipation Industry Chain Structure Analysis
1.5 Opioid-Induced Constipation Industry Development Overview
1.5.1 Opioid-Induced Constipation Product History Development Overview
1.5.1 Opioid-Induced Constipation Product Market Development Overview
1.6 Opioid-Induced Constipation Global Market Comparison Analysis
1.6.1 Opioid-Induced Constipation Global Import Market Analysis
1.6.2 Opioid-Induced Constipation Global Export Market Analysis
1.6.3 Opioid-Induced Constipation Global Main Region Market Analysis
1.6.4 Opioid-Induced Constipation Global Market Comparison Analysis
1.6.5 Opioid-Induced Constipation Global Market Development Trend Analysis

Chapter Two Opioid-Induced Constipation Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Opioid-Induced Constipation Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Opioid-Induced Constipation Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Opioid-Induced Constipation Market Analysis
3.1 Asia Opioid-Induced Constipation Product Development History
3.2 Asia Opioid-Induced Constipation Competitive Landscape Analysis
3.3 Asia Opioid-Induced Constipation Market Development Trend

Chapter Four 2018-2023 Asia Opioid-Induced Constipation Productions Supply Sales Demand Market Status and Forecast
4.1 2018-2023 Opioid-Induced Constipation Production Overview
4.2 2018-2023 Opioid-Induced Constipation Production Market Share Analysis
4.3 2018-2023 Opioid-Induced Constipation Demand Overview
4.4 2018-2023 Opioid-Induced Constipation Supply Demand and Shortage
4.5 2018-2023 Opioid-Induced Constipation Import Export Consumption
4.6 2018-2023 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Chapter Five Asia Opioid-Induced Constipation Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
…
…
Chapter Six Asia Opioid-Induced Constipation Industry Development Trend
6.1 2023-2027 Opioid-Induced Constipation Production Overview
6.2 2023-2027 Opioid-Induced Constipation Production Market Share Analysis
6.3 2023-2027 Opioid-Induced Constipation Demand Overview
6.4 2023-2027 Opioid-Induced Constipation Supply Demand and Shortage
6.5 2023-2027 Opioid-Induced Constipation Import Export Consumption
6.6 2023-2027 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Part III North American Opioid-Induced Constipation Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Opioid-Induced Constipation Market Analysis
7.1 North American Opioid-Induced Constipation Product Development History
7.2 North American Opioid-Induced Constipation Competitive Landscape Analysis
7.3 North American Opioid-Induced Constipation Market Development Trend

Chapter Eight 2018-2023 North American Opioid-Induced Constipation Productions Supply Sales Demand Market Status and Forecast
8.1 2018-2023 Opioid-Induced Constipation Production Overview
8.2 2018-2023 Opioid-Induced Constipation Production Market Share Analysis
8.3 2018-2023 Opioid-Induced Constipation Demand Overview
8.4 2018-2023 Opioid-Induced Constipation Supply Demand and Shortage
8.5 2018-2023 Opioid-Induced Constipation Import Export Consumption
8.6 2018-2023 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Chapter Nine North American Opioid-Induced Constipation Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
…
…
Chapter Ten North American Opioid-Induced Constipation Industry Development Trend
10.1 2023-2027 Opioid-Induced Constipation Production Overview
10.2 2023-2027 Opioid-Induced Constipation Production Market Share Analysis
10.3 2023-2027 Opioid-Induced Constipation Demand Overview
10.4 2023-2027 Opioid-Induced Constipation Supply Demand and Shortage
10.5 2023-2027 Opioid-Induced Constipation Import Export Consumption
10.6 2023-2027 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Part IV Europe Opioid-Induced Constipation Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Opioid-Induced Constipation Market Analysis
11.1 Europe Opioid-Induced Constipation Product Development History
11.2 Europe Opioid-Induced Constipation Competitive Landscape Analysis
11.3 Europe Opioid-Induced Constipation Market Development Trend

Chapter Twelve 2018-2023 Europe Opioid-Induced Constipation Productions Supply Sales Demand Market Status and Forecast
12.1 2018-2023 Opioid-Induced Constipation Production Overview
12.2 2018-2023 Opioid-Induced Constipation Production Market Share Analysis
12.3 2018-2023 Opioid-Induced Constipation Demand Overview
12.4 2018-2023 Opioid-Induced Constipation Supply Demand and Shortage
12.5 2018-2023 Opioid-Induced Constipation Import Export Consumption
12.6 2018-2023 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Chapter Thirteen Europe Opioid-Induced Constipation Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
…
…
Chapter Fourteen Europe Opioid-Induced Constipation Industry Development Trend
14.1 2023-2027 Opioid-Induced Constipation Production Overview
14.2 2023-2027 Opioid-Induced Constipation Production Market Share Analysis
14.3 2023-2027 Opioid-Induced Constipation Demand Overview
14.4 2023-2027 Opioid-Induced Constipation Supply Demand and Shortage
14.5 2023-2027 Opioid-Induced Constipation Import Export Consumption
14.6 2023-2027 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Part V Opioid-Induced Constipation Marketing Channels and Investment Feasibility

Chapter Fifteen Opioid-Induced Constipation Marketing Channels Development Proposals Analysis
15.1 Opioid-Induced Constipation Marketing Channels Status
15.2 Opioid-Induced Constipation Marketing Channels Characteristic
15.3 Opioid-Induced Constipation Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Opioid-Induced Constipation New Project Investment Feasibility Analysis
17.1 Opioid-Induced Constipation Market Analysis
17.2 Opioid-Induced Constipation Project SWOT Analysis
17.3 Opioid-Induced Constipation New Project Investment Feasibility Analysis

Part VI Global Opioid-Induced Constipation Industry Conclusions

Chapter Eighteen 2018-2023 Global Opioid-Induced Constipation Productions Supply Sales Demand Market Status and Forecast
18.1 2018-2023 Opioid-Induced Constipation Production Overview
18.2 2018-2023 Opioid-Induced Constipation Production Market Share Analysis
18.3 2018-2023 Opioid-Induced Constipation Demand Overview
18.4 2018-2023 Opioid-Induced Constipation Supply Demand and Shortage
18.5 2018-2023 Opioid-Induced Constipation Import Export Consumption
18.6 2018-2023 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Chapter Nineteen Global Opioid-Induced Constipation Industry Development Trend
19.1 2023-2027 Opioid-Induced Constipation Production Overview
19.2 2023-2027 Opioid-Induced Constipation Production Market Share Analysis
19.3 2023-2027 Opioid-Induced Constipation Demand Overview
19.4 2023-2027 Opioid-Induced Constipation Supply Demand and Shortage
19.5 2023-2027 Opioid-Induced Constipation Import Export Consumption
19.6 2023-2027 Opioid-Induced Constipation Cost Price Production Value Gross Margin

Chapter Twenty Global Opioid-Induced Constipation Industry Research Conclusions



★調査レポート[世界のオピオイド誘発性便秘市場2023-2027] (コード：DMN23J1632)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオピオイド誘発性便秘市場2023-2027]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のバイオ外科手術市場2023-2027
  • 世界のティアムリン市場2023-2027
  • 世界の血圧計市場2023-2027
  • 世界の検眼計市場2023-2027
  • 世界の注射ペン市場2023-2027
  • 世界の医療情報市場2023-2027
  • 世界のサージカルフック市場2023-2027
  • 世界のフェイシャルエステ市場2023-2027
  • 世界の手術用顕微鏡市場2023-2027

    • ◆H&Iグローバルリサーチのお客様（例）◆